Patents by Inventor Raymond Wenhou ZHOU

Raymond Wenhou ZHOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycan-dependent Immunotherapeutic Molecules
    Publication number: 20230310637
    Abstract: The present invention relates to compositions and methods for treating cancer. The invention makes use of peptides, nucleic acids encoding such peptides, and cells expressing such peptides, where the peptide comprises a tumor-associated carbohydrate antigen (TACA)-binding domain.
    Type: Application
    Filed: June 5, 2023
    Publication date: October 5, 2023
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Michael DEMETRIOU, Raymond Wenhou ZHOU
  • Glycan-dependent immunotherapeutic molecules
    Patent number: 11666660
    Abstract: The present invention relates to compositions and methods for treating cancer. The invention makes use of peptides, nucleic acids encoding such peptides, and cells expressing such peptides, where the peptide comprises a tumor-associated carbohydrate antigen (TACA)-binding domain.
    Type: Grant
    Filed: December 28, 2020
    Date of Patent: June 6, 2023
    Assignee: The Regents of The University of California
    Inventors: Michael Demetriou, Raymond Wenhou Zhou
  • Glycan-dependent Immunotherapeutic Molecules
    Publication number: 20210113709
    Abstract: The present invention relates to compositions and methods for treating cancer. The invention makes use of peptides, nucleic acids encoding such peptides, and cells expressing such peptides, where the peptide comprises a tumor-associated carbohydrate antigen (TACA)-binding domain.
    Type: Application
    Filed: December 28, 2020
    Publication date: April 22, 2021
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Michael DEMETRIOU, Raymond Wenhou ZHOU
  • Glycan-dependent immunotherapeutic molecules
    Patent number: 10925972
    Abstract: The present invention relates to compositions and methods for treating cancer. The invention makes use of peptides, nucleic acids encoding such peptides, and cells expressing such peptides, where the peptide comprises a tumor-associated carbohydrate antigen (TACA)-binding domain.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: February 23, 2021
    Assignee: The Regents of The University of California
    Inventors: Michael Demetriou, Raymond Wenhou Zhou
  • Glycan-dependent immunotherapeutic molecules
    Patent number: 10881744
    Abstract: The present invention relates to compositions and methods for treating cancer. The invention makes use of peptides, nucleic acids encoding such peptides, and cells expressing such peptides, where the peptide comprises a tumor-associated carbohydrate antigen (TACA)-binding domain.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: January 5, 2021
    Assignee: The Regents of The University of California
    Inventors: Michael Demetriou, Raymond Wenhou Zhou
  • Glycan-dependent Immunotherapeutic Molecules
    Publication number: 20180169260
    Abstract: The present invention relates to compositions and methods for treating cancer. The invention makes use of peptides, nucleic acids encoding such peptides, and cells expressing such peptides, where the peptide comprises a tumor-associated carbohydrate antigen (TACA)-binding domain.
    Type: Application
    Filed: April 29, 2016
    Publication date: June 21, 2018
    Applicant: The Regents of the University of California
    Inventors: Michael DEMETRIOU, Raymond Wenhou ZHOU